Danish researchers from DTU Systems Biology have developed a new innovative technology called the TumorTracer, which diagnoses cancer in two days.
Denmark is the highest ranking European country on this year's Global Creativity Index.
A new prehospital solution, which enables better patient treatment, has been installed in all Danish ambulances.
Hospitals in the Capital Region of Denmark and Region Zealand will soon implement the new technology, Medical Device Integration Platform (MDI), which enables better treatment and improves patient safety.
A new app called XHALE from the Danish Cancer Society helps young people quit smoking by providing tips and advice from Danish celebrities.
The U.S. Food and Drug Administration (FDA) approves the insulin preparations Tresiba and Ryzodeg by Danish pharmaceutical company, Novo Nordisk.
Danish researchers are currently working on a computer program with the aim to identify women at high risk of developing breast cancer.
The countdown has started. In one month, the international Hospital + Innovation Congress kicks off. Register now and join the international health community at this exclusive event.
The Danish biopharmaceutical company, Bavarian Nordic, receives major contract from its Dutch partner, Janssen, as part of an advanced development of prime-boost Ebola vaccine regimen.
New research from the Danish Cancer Society shows that whole grains reduce the risk of premature death and of dying from cancer.